Consequently, CD64 at 2 and 6 hours postoperatively is an effective biomarker for early prediction of SIRS after lithotripsy, but its validity in early prediction of SIRS after PCNL still needs further validation. This evidence concerns the gene FCGR1A and systemic inflammatory response syndrome.